These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23259796)
1. Role of matrix metaloproteases in idiopathic pulmonary fibrosis. Pardo A; Selman M Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S9. PubMed ID: 23259796 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Pardo A; Selman M Proc Am Thorac Soc; 2006 Jun; 3(4):383-8. PubMed ID: 16738205 [TBL] [Abstract][Full Text] [Related]
3. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Pardo A; Cabrera S; Maldonado M; Selman M Respir Res; 2016 Mar; 17():23. PubMed ID: 26944412 [TBL] [Abstract][Full Text] [Related]
4. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro. Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067 [TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease]. Yoshimura K Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():20-31. PubMed ID: 8007466 [TBL] [Abstract][Full Text] [Related]
6. R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior. Munguía-Reyes A; Balderas-Martínez YI; Becerril C; Checa M; Ramírez R; Ortiz B; Meléndez-Zajgla J; Pardo A; Selman M Am J Respir Cell Mol Biol; 2018 Jul; 59(1):65-76. PubMed ID: 29345973 [TBL] [Abstract][Full Text] [Related]
7. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as potential targets for progressive pulmonary fibrosis. Rajasekaran S; Rajaguru P; Sudhakar Gandhi PS Front Pharmacol; 2015; 6():254. PubMed ID: 26594173 [TBL] [Abstract][Full Text] [Related]
9. Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis. Maldonado M; Salgado-Aguayo A; Herrera I; Cabrera S; Ortíz-Quintero B; Staab-Weijnitz CA; Eickelberg O; Ramírez R; Manicone AM; Selman M; Pardo A Am J Respir Cell Mol Biol; 2018 Jul; 59(1):77-86. PubMed ID: 29373068 [TBL] [Abstract][Full Text] [Related]
10. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Clarke DL; Carruthers AM; Mustelin T; Murray LA Fibrogenesis Tissue Repair; 2013 Nov; 6(1):20. PubMed ID: 24279676 [TBL] [Abstract][Full Text] [Related]
11. Approaching the degradome in idiopathic pulmonary fibrosis. Pardo A; Selman M; Kaminski N Int J Biochem Cell Biol; 2008; 40(6-7):1141-55. PubMed ID: 18207447 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype. Epstein Shochet G; Wollin L; Shitrit D Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550 [TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis? Ruan W; Ying K Pathol Res Pract; 2010 Aug; 206(8):537-43. PubMed ID: 20452131 [TBL] [Abstract][Full Text] [Related]